- Home
- SSP vs RGC Comparison
SSP vs RGC Comparison
Compare SSP & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSP
- RGC
- Stock Information
- Founded
- SSP 1878
- RGC 2014
- Country
- SSP United States
- RGC Hong Kong
- Employees
- SSP N/A
- RGC N/A
- Industry
- SSP Broadcasting
- RGC Medicinal Chemicals and Botanical Products
- Sector
- SSP Industrials
- RGC Health Care
- Exchange
- SSP Nasdaq
- RGC Nasdaq
- Market Cap
- SSP 173.3M
- RGC 171.1M
- IPO Year
- SSP 1988
- RGC 2021
- Fundamental
- Price
- SSP $1.78
- RGC $6.69
- Analyst Decision
- SSP Buy
- RGC
- Analyst Count
- SSP 2
- RGC 0
- Target Price
- SSP $7.75
- RGC N/A
- AVG Volume (30 Days)
- SSP 652.1K
- RGC 207.6K
- Earning Date
- SSP 11-01-2024
- RGC 10-25-2024
- Dividend Yield
- SSP N/A
- RGC N/A
- EPS Growth
- SSP N/A
- RGC N/A
- EPS
- SSP N/A
- RGC N/A
- Revenue
- SSP $2,317,391,000.00
- RGC N/A
- Revenue This Year
- SSP $8.99
- RGC N/A
- Revenue Next Year
- SSP N/A
- RGC N/A
- P/E Ratio
- SSP N/A
- RGC N/A
- Revenue Growth
- SSP N/A
- RGC N/A
- 52 Week Low
- SSP $1.77
- RGC $3.03
- 52 Week High
- SSP $9.35
- RGC $32.44
- Technical
- Relative Strength Index (RSI)
- SSP 30.88
- RGC 44.16
- Support Level
- SSP $1.99
- RGC $6.55
- Resistance Level
- SSP $2.19
- RGC $8.67
- Average True Range (ATR)
- SSP 0.14
- RGC 0.84
- MACD
- SSP -0.00
- RGC -0.28
- Stochastic Oscillator
- SSP 1.75
- RGC 5.19
About SSP E.W. Scripps Company (The)
The E W Scripps Co is a media enterprise with interests in local and national media brands. It owns and operates a collection of daily and community newspapers in medium-sized cities in the southern and western portions of the United States. The company's operating segment includes Local Media, Scripps Networks, and Other. It generates maximum revenue from the Local Media segment. The Local Media segment includes local broadcast stations and their related digital operations.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional Chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.